| Antigen: | Integrin alpha V ß3 (CD51/61; Osteoclast Functional Antigen) |
| Clone: | 23C6 |
| Subclass | IgG1 |
| Species Raised In: | Balb/c |
| Immunogen: | A cell suspension containing osteoclasts from osteoclastomas. |
| Positive Control: | Tonsil |
| Cross Reactivity: | Human |
| Applications: | Acetone, FACS, Frozen, Immunoprecipitation, Neutralising |
| Growth Conditions: | DMEM + 5% FCS |
| Fusion Partner: | P3X63Ag8.653 |
| Relevance: | Integrins are heterodimeric cell surface receptors composed of alpha and beta subunits, which mediate cell-cell and cell-extracellular matrix attachments. Aberrant integrin expression has been found in many epithelial tumours. Changes in integrin expression have been shown to be important for the growth and early metastatic capacity of melanoma cells. Integrin alpha V associates with integrin beta3 to form the osteoclast functional antigen (vitronectin receptor). Integrin alpha V is found in osteoclasts, placenta, melanoma cell lines and some epithelial cell lines. Expression of integrin alpha V increases with melanoma progression. 23C6 may be useful for bone resorption modulation, osteoclast identification, receptor purification, malignant melanoma identification and treatment. |
| References: | Horton MA et al. 1985. Cancer Res. 45(11 Pt2):5663-9. PMID: 4053038 Read more |
| Notes: | 125/124 kDa (reduced), 150kDa (non-reduced) |
© Cancer Research Technology 2012